Replies to post #70009 on Titan Medical Inc (TMDIF)

[SPORT19]

Replaced "engineering verification units" with "engineering confidence build"
Anyone who invests based on Titan timelines will most likely be very disappointed. That's the history here folks, and MacNally has been no different.

[SavageWildlings]

This filing means either one of these two things...

Titan wants to go at it alone and this is what it will take.

Or

They will partner. Partnership is a total possibility given their patents on snake and effectors.

In the end, we will come out positive but by how much? It could be super painful if they decide to continue with dilution as they go at it alone or partner up and not get as much bang for the buck.

GLTA

[investinthefuture]

What could be interesting is the impact of the R/S on some of the warrants.

Let’s say they do a 30-1 at .25, resulting in a NASDAQ IPO at 7.50. They choose not to raise any capital at that time. The uplist results in larger investors being able to get in, creating demand that is largely non-existent now. Titan benefits from the same kind of speculation we’ve seen in other surgical robotic stocks.

The PPS runs past $15 (that’s .50 pre RS) on some well-timed news. This puts many of the more recent warrant tranches in the money, funding the company without further dilution (the warrants are already baked into the PPS now)

The thing that’s hurting the company right now isn’t technology or the will to succeed. What’s hurting it is limited access to the capital needed for a project of this size. Fix that, and we are back in business.